First-in-human study of dosimetry, safety and efficacy for [177Lu]Lu-P15-073: a novel bisphosphonate-based radioligand therapy (RLT) agent for bone metastases.

Autor: Zhao, Ruiyue (AUTHOR), Lv, Jie (AUTHOR), Li, Mingzhao (AUTHOR), Xu, Siran (AUTHOR), Liang, Wenhua (AUTHOR), Lin, Xinqing (AUTHOR), Gu, Di (AUTHOR), Zeng, Guohua (AUTHOR), Jin, Wenbin (AUTHOR), Yan, Qingsong (AUTHOR), Zhong, Huizhen (AUTHOR), Alexoff, David (AUTHOR), Ploessl, Karl (AUTHOR), Zhu, Lin1,2 (AUTHOR) zhulin@bnu.edu.cn, Kung, Hank F.3,4 (AUTHOR) kunghf@gmail.com, Wang, Xinlu1 (AUTHOR) 71lu@163.com
Zdroj: European Journal of Nuclear Medicine & Molecular Imaging. Oct2024, p1-11.
Databáze: Academic Search Ultimate
Externí odkaz: